Click to copy, then share by pasting into your messages, comments, social media posts and websites.
Click to copy, then add into your webpages so users can view and engage with this video from your site.
Report Content
We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.
Thank you for submitting your report
We will investigate and take the appropriate action.
The Pfizer documents - Dr. John Campbell
Public Health and Medical Professionals for Transparency, Pfizer / FDA FOI
https://phmpt.org
Request, Freedom of Information Act (FOIA)
https://phmpt.org/wp-content/uploads/2021/10/IR0546-FDA-Pfizer-Approval-FINAL.pdf
Against FDA
https://phmpt.org/wp-content/uploads/2021/10/001-Complaint-101021.pdf
List of downloadable documents
https://phmpt.org/pfizers-documents/
5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021
https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
Adverse event reports
01 December 2020 through 28 February 2021
Cumulatively, through 28 February 2021,
a total of 42,086 case reports (25,379 medically confirmed and 16,707 non-medically confirmed)
containing 158,893 events.
Most cases (34,762) were received from United States (13,739), United Kingdom (13,404) Italy (2,578), Germany (1,913), France (1,506), Portugal (866) and Spain (756) the remaining 7,324 were distributed among 56 other countries.
Fatal, 1,223
Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA
(Approval, 21st August 2021)
Acting FDA Commissioner Janet Woodcock, M.D.
While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.
System Organ Classes (SOCs) that contained the greatest number (≥2%) of events, in the overall dataset, were General disorders and administration site conditions (51,335 AEs), Nervous system disorders (25,957), Musculoskeletal and connective tissue disorders (17,283),
Gastrointestinal disorders (14,096), Skin and subcutaneous tissue disorders (8,476), Respiratory, thoracic and mediastinal disorders (8,848), Infections and infestations (4,610), Injury, poisoning and procedural complications (5,590), and Investigations (3,693).
Cardiovascular AESIs
Number of cases: 1403 (3.3% of the total PM dataset), of which 241 are medically confirmed and 1162 are non-medically confirmed; 5. SUMMARY AND CONCLUSION Review of the available data for this cumulative PM experience, confirms a favorable benefit: risk balance for BNT162b2.
Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research
“Our scientific and medical experts conducted an incredibly thorough and thoughtful evaluation of this vaccine. We evaluated scientific data and information included in hundreds of thousands of pages, conducted our own analyses of Comirnaty’s safety and effectiveness…
mirrored from https://www.youtube.com/watch?v=7YOD9drZasM
Category | Spirituality & Faith |
Sensitivity | Normal - Content that is suitable for ages 16 and over |
Playing Next
Related Videos
International Law? — Corbett Report
4 days, 22 hours ago
Kmart in the 70s & 80s - Why We LOVED IT — The History Lounge
5 days, 6 hours ago
"Tyrants Disarm The People They Intend To Oppress" — Chip Roy
5 days, 9 hours ago
The Second Amendment: A Knife in a Gunfight — Ted Weiland
5 days, 21 hours ago
Suffering From a Medical Coincidence? — HT: Spacebusters
2 weeks, 2 days ago
Warning - This video exceeds your sensitivity preference!
To dismiss this warning and continue to watch the video please click on the button below.
Note - Autoplay has been disabled for this video.